Sildenafil is usually a strong and selective inhibitor of cGMP-unique phosphodiesterase kind five (PDE5), which can be liable for degradation of cGMP inside the corpus cavernosum. The molecular framework of sildenafil is analogous to that of cGMP and acts like a competitive binding agent of PDE5 in the corpus cavernosum, causing a lot more cGMP and